Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Gene delivery and immunomodulatory effects of plasmid DNA associated with Branched Amphiphilic Peptide Capsules

Full text
Author(s):
Show less -
Avila, L. A. ; Aps, L. R. M. M. ; Ploscariu, N. ; Sukthankar, P. ; Guo, R. ; Wilkinson, K. E. ; Games, P. ; Szoszkiewicz, R. ; Alves, R. P. S. ; Diniz, M. O. ; Fang, Y. ; Ferreira, L. C. S. ; Tomich, J. M.
Total Authors: 13
Document type: Journal article
Source: JOURNAL OF CONTROLLED RELEASE; v. 241, p. 15-24, NOV 10 2016.
Web of Science Citations: 8
Abstract

We recently reported on a new class of branched amphiphilic peptides that associate with double stranded DNA and promote in vitro transfection of eukaryotic cells. In the present study, we tested a different formulation in which plasmid DNA associates with the surface of preformed 20-30 nm cationic capsules formed through the self-assembly of the two branched amphiphilic peptides. Under these conditions, the negatively charged DNA interacts with the cationic surface of the Branched Amphiphilic Peptide Capsules (BAPCs) through numerous electrostatic interactions generating peptide-DNA complexeswith sizes ranging from50 to 250 nm. The BAPCs-DNA nanoparticles are capable of delivering plasmid DNA of different size into cells in culture, yielding high transfection rates and minimal cytotoxicity. Furthermore, BAPCs were tested for in vivo delivery of a DNA vaccine previously designed to activate immune responses and capable of controlling tumors induced by type 16 human papilloma virus (HPV-16). The BAPCs-DNA nanoparticles enhanced the vaccine-induced antitumor protection and promoted activation of murine dendritic cells without significant toxic effects. These results indicate that branched amphiphilic oligo-peptides nanoparticles represent a new and promising nonviral DNA/gene delivery approach endowing immunomodulatory properties for DNA vaccines. (C) 2016 Elsevier B.V. All rights reserved. (AU)

FAPESP's process: 13/15360-2 - New therapeutic frontiers against tumors caused by human papilloma virus (HPV): experimental evaluation of the chemotherapy in association to vaccine strategies
Grantee:Luana Raposo de Melo Moraes Aps
Support Opportunities: Scholarships in Brazil - Doctorate